Cancer immunotherapy /

Saved in:
Bibliographic Details
Edition:First edition.
Imprint:Cambridge, MA, United States : Elsevier Academic Press, 2019.
©2019
Description:1 online resource (xvi, 335 pages) : color illustrations.
Language:English
Series:Progress in molecular biology and translational science, 1877-1173 ; volume one hundred and sixty four
Progress in molecular biology and translational science ; v. 164.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/12379669
Hidden Bibliographic Details
Other authors / contributors:Teplow, David B., editor.
ISBN:9780128165768
0128165766
9780128165751
0128165758
Notes:Includes bibliographical references.
Description based on online resource; title from digital title page (viewed on November 01, 2019).
Summary:Cancer Immunotherapy, Volume 164 in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to different approaches to cancer immunotherapy, with this release focusing on TNFR2 in cancer immunology and immunotherapy, From the Hellstrom paradox towards cancer cure, CAR T-cell treatment of T-cell malignancy, Immunotherapy of pancreatic cancer, Cancer stem cell immunology/immunotherapy, Cytokine release syndrome, Tumor cell-based mechanisms of resistance to immune attack, and Mushroom compounds in cancer immunotherapy.

MARC

LEADER 00000cam a2200000Ki 4500
001 12379669
005 20200828230845.4
006 m o d
007 cr mn|---auuua
008 190805t20192019maua o 000 0 eng
019 |a 1112114468 
020 |a 9780128165768  |q electronic book 
020 |a 0128165766  |q electronic book 
020 |z 9780128165751  |q hardcover 
020 |z 0128165758  |q hardcover 
035 |a (OCoLC)1111636869  |z (OCoLC)1112114468 
035 9 |a (OCLCCM-CC)1111636869 
040 |a AU@  |b eng  |e rda  |c AU@  |d OHS  |d OCLCO  |d OCLCF  |d SFB  |d YDXIT  |d OCLCO  |d DKU  |d OPELS  |d OCLCA 
049 |a MAIN 
050 4 |a RC271.I45  |b C363 2019 
060 4 |a QZ 266 
245 0 0 |a Cancer immunotherapy /  |c edited by David B. Teplow. 
250 |a First edition. 
264 1 |a Cambridge, MA, United States :  |b Elsevier Academic Press,  |c 2019. 
264 4 |c ©2019 
300 |a 1 online resource (xvi, 335 pages) :  |b color illustrations. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a computer  |b c  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/c 
338 |a online resource  |b cr  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/cr 
490 1 |a Progress in molecular biology and translational science,  |x 1877-1173 ;  |v volume one hundred and sixty four 
504 |a Includes bibliographical references. 
505 0 |a Preface / David B. Teplow -- 1. From the Hellstrom paradox towards cancer cure / Karl Erik Hellstrom and Ingegerd Hellstrom -- 2. Bioinformatic methods for cancer neoantigen prediction / Sebastian Boegel, John C. Castle, Julia Kodysh, Timothy O'Donnell, Alex Rubinsteyn -- 3. Tumor mechanisms of resistance to immune attack / David J. Zahavi, Louis M. Weiner -- 4. TNFR2-expressing CD4+ Foxp3+ regulatory T cells in cancer immunology and immunotherapy / Jiang He, Ruixin Li, Yibo Chen, Yuanjia Hu, Xin Chen -- 5. Cancer stem cell immunology and immunotherapy: harnessing the immune system against cancer's source / Roberto Ruiu, Lidia Tarone, Valeria Rolih, Giuseppina Barutello, Elisabetta Bolli, Federica Riccardo, Federica Cavallo, Laura Conti -- 6. Immunotherapy of pancreatic cancer / Yoshiaki Sunami, Jörg Kleeff -- 7. Synergistic combination of oncolytic virotherapy with CAR T-cell therapy / Adam Ajina, John Maher -- 8. Application of CAR T cells for the treatment of solid tumors / Jonathan F. Khan, Abdul Salam Khan, Renier J. Brentjens. 
520 |a Cancer Immunotherapy, Volume 164 in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to different approaches to cancer immunotherapy, with this release focusing on TNFR2 in cancer immunology and immunotherapy, From the Hellstrom paradox towards cancer cure, CAR T-cell treatment of T-cell malignancy, Immunotherapy of pancreatic cancer, Cancer stem cell immunology/immunotherapy, Cytokine release syndrome, Tumor cell-based mechanisms of resistance to immune attack, and Mushroom compounds in cancer immunotherapy. 
588 |a Description based on online resource; title from digital title page (viewed on November 01, 2019). 
650 0 |a Cancer  |x Immunotherapy.  |0 http://id.loc.gov/authorities/subjects/sh87002642 
650 0 |a Cancer  |x Research.  |0 http://id.loc.gov/authorities/subjects/sh85019539 
650 2 |a Neoplasms. 
650 7 |a Cancer  |x Immunotherapy.  |2 fast  |0 (OCoLC)fst00845386 
650 7 |a Cancer  |x Research.  |2 fast  |0 (OCoLC)fst00845497 
650 2 |a Neoplasms  |x therapy. 
655 0 |a Electronic books 
700 1 |a Teplow, David B.,  |e editor.  |0 http://id.loc.gov/authorities/names/nb2012015348  |1 http://viaf.org/viaf/312857738 
830 0 |a Progress in molecular biology and translational science ;  |v v. 164.  |0 http://id.loc.gov/authorities/names/no2009049039 
903 |a HeVa 
929 |a oclccm 
999 f f |i 2fc33057-8bd3-59f0-9eba-fadd8a3c5d8a  |s 71ed6e87-0957-5e10-97de-795783a23dde 
928 |t Library of Congress classification  |a RC271.I45 C363 2019  |l Online  |c UC-FullText  |u https://www.sciencedirect.com/science/bookseries/18771173/164  |z Elsevier  |g ebooks  |i 11979757